Johnson & Johnson MedTech named Kurt Van den Bosch as CFO.
In his new role, he will provide financial leadership to the global J&J MedTech organization, according to a May 9 email to Becker's.
Previously, Mr. Van den Bosch was area vice president of mid-sized markets for J&J MedTech's Europe, the Middle East and Africa regions. He joined Janssen Pharmaceuticals in Belgium in 1990.